-
2 weeks ago | 
cellandgene.com | Tyler Menichiello |Kaitlyn R Rouillard |Rachel Ward
Introducing a new way to source solutions for improving, refining, and optimizing your CGT manufacturing! From April 8-10, Life Science Connect brings you the next virtual showcase from its network of trusted communities: Cell & Gene Therapy Tech Expo.
-
2 weeks ago | 
bioprocessonline.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
As I mentioned in my coverage of this year’s BioProcess International (BPI) U.S. West conference, continuous manufacturing was a hot topic of conversation — and one that isn’t going away any time soon.
-
2 weeks ago | 
bioprocessonline.com | Tyler Menichiello |Eva Fong |Andi Ushijima
Webinar: Sustainable Manufacturing Through Efficient BioProduction Unit OperationsJoin our webinar to explore sustainable bioprocessing solutions, tackling plastic waste with biobased consumables, process intensification, and optimized operations. Learn how seed train intensification, high-density cell banking, and efficient bioreactor scaling can reduce the environmental footprint.
-
3 weeks ago | 
bioprocessonline.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
While at this year’s BioProcess International (BPI) U.S. West conference, I struck up a conversation with Jared Dopp, Ph.D., a senior scientist in upstream biologics development at Bristol Myers Squibb.
-
3 weeks ago | 
bioprocessonline.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
While at this year’s BioProcess International U.S. West (BPI West), I regrettably couldn’t make it to many cell-therapy-specific sessions.
-
3 weeks ago | 
cellandgene.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
While at this year’s BioProcess International U.S. West (BPI West), I regrettably couldn’t make it to many cell-therapy-specific sessions.
-
4 weeks ago | 
bioprocessonline.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
At this year’s BioProcess International (BPI) U.S. West conference, I attended a keynote presentation titled “Advances In Machine Learning For Cell Line Development To Predict Better Clones, Reduce Timelines, And Experiments” by Nathan Lewis, Ph.D., professor and Georgia Research Alliance (GRA) Eminent Scholar at the University of Georgia.
-
4 weeks ago | 
bioprocessonline.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
Last week, I took a pilgrimage to beautiful San Diego to cover the BioProcess International (BPI) U.S. West conference. Per the event staff, there were around 800 leaders and industry professionals in attendance, and with so many people to meet and sessions to attend, my only regret was not being able to clone myself to experience more!
However, I attended as many sessions as possible and connected with some great people.
-
1 month ago | 
cellandgene.com | Christopher Ohms |Tyler Menichiello |Cal Collins
Webinar: Critical Imaging Risks in GLP-1 and Neurology Studies: What You Need to KnowClinical trials in GLP-1 and neurology rely increasingly on imaging, but challenges often go unaddressed. This webinar covers early indicators of imaging issues, preclinical insights, expanding imaging requirements, and hidden risks.
-
1 month ago | 
cellandgene.com | Tyler Menichiello
By Tyler Menichiello, contributing editor
The advent of CAR-T marks an inflection point in the history of medicine. This modality, which used to resemble science fiction more than reality, has exploded into a multibillion-dollar market. The result is a space bursting with innovation at every turn. Hundreds of companies are working (and in many cases, competing) to develop next-generation CAR-T therapies and inventing unique ways to overcome the modality’s inherent challenges.
